Course Information
6th International Symposium on Malignant Pleural Mesothelioma

UCLA Meyer and Renee Luskin Conference Center
Los Angeles, California
September 24, 2016

Download: [ PDF ]

Course Description

Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is a rare tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, typically only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies and immunotherapy. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 30 years of experience with treating patients with MPM, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.

Taget Audience

  • Pulmonary physicians who are frequently involved in patient workups
  • Medical oncologists who are frequently involved in patient therapy
  • Mesothelioma experts who want to learn/share experiences about lung-sparing therapies
  • Patients, family, friends who desire to learn more about the disease

Registration Information

Enrollment

To enroll click here.

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
Mesothelioma
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512


By FAX

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Registration Fee

Pre-registration fee: (before September 9)

  • $150.00 - Physicians:
  • $100.00 - Nurses
  • $75.00 - Family Members & Patients
  • $25.00 - Students*
  • $400.00 - Legal Profession


Late registration fee (starting September 9)
  • $225.00 - Physicians:
  • $150.00 - Nurses
  • $100.00 - Family Members & Patients
  • $40.00 - Students*
  • $650.00 - Legal Profession
*must show student ID on-site

Refunds Cancellations must be received in writing by August 24, 2016 and will be subject to a $75 processing fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.

Faculty

Course Chair

Robert B. Cameron, MD, FACS
Professor of Clinical Cardiothoracic Surgery and Surgical Oncology
Director, Comprehensive Mesothelioma Program
David Geffen School of Medicine at UCLA
Chief, Thoracic Surgery
West Los Angeles VA Medical Center
Los Angeles, California

Guest Faculty

Edgar G. Engleman, MD
Professor of Pathology and Medicine
Stanford University School of Medicine
Palo Alto, California

Thierry M. Jahan, MD
Professor of Medicine
Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California

Edmund K. Moon, MD
Assistant Professor of Medicine
Section of Interventional Pulmonary and Thoracic Oncology
Division of Pulmonary, Allergy, and Critical Care
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Richard Morgan, PhD
Director
The Institute of Cancer Therapeutics
University of Bradford
Bradford, England

Daniel H. Sterman, MD
Thomas and Suzanne Murphy Professor of Pulmonary and Critical Care Medicine
Director, Division of Pulmonary, Critical Care and Sleep Medicine
Director, Multidisciplinary Pulmonary Oncology Program
Departments of Medicine and Cardiothoracic Surgery
NYU Langone Medical Center/NYU School of Medicine
New York, New York

Haining Yang, MD, PhD
Professor
Cancer Biology Program
University of Hawaii Cancer Center
Honolulu, Hawaii

Faculty

Fereidoun Abtin, MD
Associate Professor
Director of Thoracic Fellowship
Director of Santa Monica Outpatient Interventional Center
Department of Radiology, Thoracic Section
David Geffen School of Medicine at UCLA
Los Angeles, California

Clare Cameron
Executive Director
Pacific Heart, Lung, & Blood Institute
Los Angeles, California

Graciela Hoal, RN, NP
VA Comprehensive Mesothelioma Program
West Los Angeles VA Medical Center
Los Angeles, California

Lien Hua-Feng, RN, MSN, NP-C
Nurse Practitioner
Pacific Mesothelioma Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California

Ka-Kit Hui, MD, FACP
Wallis Annenberg Professor in Integrative
East-West Medicine
Professor, Founder and Director
UCLA Center for East-West Medicine
Department of Medicine
Chair, Collaborative Centers for Integrative Medicine
David Geffen School of Medicine at UCLA
Santa Monica, California

Olga Olevsky, MD
Health Sciences Assistant Clinical Professor
Santa Monica Oncology
David Geffen School of Medicine at UCLA
Santa Monica, California

Raymond Wong, PhD
Research Scientist
Pacific Mesothelioma Center
Pacific Heart, Lung & Blood Institute
Los Angeles, California

Program Agenda

Saturday, September 24, 2016

7:30 Registration and Breakfast
8:00 Welcome
Robert B. Cameron, MD, FACS
Morning Session I
Moderator: Robert B. Cameron, MD, FACS
8:15 Options for Intraoperative Adjuvant Therapies
Robert B. Cameron, MD, FACS
8:45 Update from Recent Mesothelioma Clinical Trials
Olga Olevsky, MD
9:15 Cryoablation in Management of Recurrent Mesothelioma
Fereidoun Abtin, MD
9:45 Discussion
10:00 Break
Morning Session II
Moderator: Olga Olevsky, MD
10:15 The Role of Immunotherapy in Advanced Pleural Mesothelioma
Thierry M. Jahan, MD
10:45 Genetic Immunotherapy for Malignant Pleural Mesothelioma
Daniel H. Sterman, MD
11:15 Targeting Dendritic Cells in Vivo for Tumor Immunotherapy
Edgar G. Engleman, MD
11:45 Discussion
12:00 Lunch
Afternoon Session I
Moderators: Robert B. Cameron, MD, FACS and Raymond Wong, PhD
1:00 HOX Genes as Targets and Markers in Mesothelioma
Richard Morgan, PhD
1:30 Adoptive Immunotherapy Utilizing Chimeric Antigen Receptor
Edmund K. Moon, MD
2:00 Harnessing the Full Potential of Immunotherapy by Targeting the Tumor Microenvironment
Raymond Wong, PhD
2:30 Mesothelioma Prevention and Early Detection - Are We There Yet?
Haining Yang, MD, PhD
3:00 Discussion
3:15 Break
Afternoon II
Moderators: Robert B. Cameron, MD, FACS and Clare Cameron
3:30 East-West Medicine Approaches to Cancer Therapy
Ka-Kit Hui, MD, FACP
4:00 The Benefits of Nurse Navigators in Mesothelioma
Lien Hua-Feng, RN, MSN, NP-C and Graciela Hoal, RN, NP
4:20 Tissue-Banking Resources for Researchers
Clare Cameron
4:40 Discussion
4:55 Concluding Remarks
Robert B. Cameron, MD, FACS
5:00 Adjourn

Objectives

At the completion of this course, participants should be able to:

  • Describe the current role of each traditional modality in multidisciplinary therapies, including surgery, radiation, and chemotherapy
  • Name the possibilities for intraoperative adjuvant therapies
  • Review the nature of MPM and the need for chronic treatment
  • Site the various types of biological and immunological therapies and their potential role in therapy

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Miscellaneous

Location

UCLA Meyer & Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252

Local Accommodations

Please note there are no room blocks reserved at any location. Any special rates are subject to change and subject to availability.

UCLA Meyer & Renee Luskin Conference Center
855-522-8252

Palomar Hotel
310-475-8711 (Ask for the UCLA rate)

The Beverly Hilton
310-274-7777 (Ask for the UCLA rate)

Parking

Self-Parking $12

The UCLA Meyer & Renee Luskin Conference Center self-parking is located in Lot 8. A parking attendant will be on duty from 7:00-9:00 AM. If you arrive outside of this time frame, please visit the parking kiosk on Westwood Plaza to pay for your parking permit. Participants are responsible to pay for their own parking charges at a rate of $12 per vehicle, cash only.

Valet parking is reserved only for overnight guests at the Center.

Directions

From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. There is a walkway that connects the structure to the Center.